ANNEX ISupplementary provisions
ANNEX I Pursuant to paragraph 3 of Decision XII/2 of the Twelfth Meeting of the Parties to the Montreal Protocol on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (MDIs), the following countries have determined that, due to the presence of suitable non-CFC MDIs, CFCs no longer qualify as ‘essential’ under the Protocol when combined with following active ingredients: Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp Table 1 Short acting beta agonist bronchodilators Country Salbutamol Terbutaline Fenoterol Orciprenaline Reproterol Carbuterol Hexoprenaline Pirbuterol Clenbuterol Bitolterol Procaterol Austria X X X X X X X X X X X Belgium X X X X X X X X X X X Cyprus X X X X X X X X X X X Czech Republic X X X X X X X X X X X Denmark X Estonia X X X X X X X X X X X Finland X X X X X X X X X X X France X X X X X X X X X X X Germany X X X X X X X X X X X Greece X X X X X X X X X X X Hungary X X X X X X X X X X X Ireland X X X X X X X X X X X Italy X X X X X X X X X X X Latvia X X X X X X X X X X X Lithuania X X X X X X X X X X X Luxembourg X X X X X X X X X X X Malta X X X X X X X X X X X Netherlands X X X X X X X X X X X Poland X Portugal X X X X X X X X X X X Norway X X X X X X X X X X X Slovakia X X X X X X X X X X X Slovenia X X X X X X X X X X X Spain X X X X X X X X X X X Sweden X X X X X X X X X X X United Kingdom X Table 2 Inhaled steroids Country Beclomethasone Dexamethasone Flunisolide Fluticasone Budesonide Triamcinolone Austria X X X X X X Belgium X X X X X X Cyprus Czech Republic X X X X X X Denmark X X Estonia X X X X X X Finland X X France X X Germany X X X X X X Greece Hungary X X X X X X Ireland X X Italy X X X X X X Latvia X X X X X X Lithuania X X X X X X Luxembourg X X X X X X Malta X X Poland Portugal X X X The Netherlands X X X X X X Norway Slovakia X X X X X X Slovenia X X X X X X Spain X X Sweden X X United Kingdom X Table 3 Non steroidal anti inflammatories Country Cromoglicic acid Nedrocromil Austria X X Belgium X X Cyprus X X Czech Republic X X Denmark X X Estonia X X Finland X X France X X Germany X X Greece X X Hungary X Ireland Italy X X Latvia X X Lithuania X X Luxembourg X Malta X X Poland Portugal X The Netherlands X X Norway Slovakia X X Slovenia X X Spain X Sweden X X United Kingdom Table 4 Anticholinergic bronchodilators Country Ipratropium bromide Oxitropium Bromide Austria X X Belgium X X Cyprus X X Czech Republic X X Denmark X X Estonia X X Finland X X France Germany X X Greece X X Hungary X X Ireland X X Italy Latvia X X Lithuania X X Luxembourg X X Malta X X Netherlands X X Poland Portugal X Norway Slovakia X X Slovenia X X Spain X X Sweden X X United Kingdom X X Table 5 Long acting beta agonist bronchodilators Country Formoterol Salmeterol Austria X X Belgium X X Cyprus X Czech Republic X X Denmark Estonia X X Finland X X France X X Germany X X Greece Hungary X X Ireland X X Italy X X Latvia X X Lithuania X X Luxembourg X X Malta X X Netherlands X Poland Portugal Norway Slovakia X X Slovenia X X Spain X Sweden X X United Kingdom Table 6 Combinations of active ingredients in a single MDI Country Austria X All products Belgium X All products Cyprus Czech Republic X All products Denmark Estonia Finland X All products France X All products Germany X All products Greece Hungary X All products Ireland Italy Budesonide + Fenoterol Fluticasone + Salmeterol Latvia X All products Lithuania X All products Luxembourg X All products Malta X All products Netherlands Poland Portugal Norway Slovakia X All products Slovenia X All products Spain Sweden X All products United Kingdom